Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Incidence and Survival of Multiple Myeloma; A Population-Based Study on 10 961 Patients Diagnosed 1982-2017

Øystein Langseth, MD, Tor Åge Myklebust, M.sc, PhD, Tom Børge Johannesen, MD PhD, Øyvind Hjertner, MD PhD, Anders Waage, MD PhD

Blood (2019) 134 (Supplement_1): 4380.

https://doi.org/10.1182/blood-2019-129816

Published: 2019

Journal Articles

Factors Relating to the Favorable Outcome in Reduced-Dose R-CHOP Therapy for Elderly DLBCL Patients

Keiko Ono, MD, Hideki Tsujimura, MD PhD, Satoshi Maruyama, MD, Akiyasu Satou, MD, Takeaki Sugawara, MD PhD, Kyoya Kumagai, MD

Blood (2018) 132 (Supplement 1): 4241.

https://doi.org/10.1182/blood-2018-99-110699

Published: 2018

Journal Articles

Management of Diffuse Large B Cell Lymphoma in the Oldest Old—Insight into the Management Decision Process: A Canadian Perspective

Annie Lacerte, MD PhD, Marie-Pier Bleau, MD, Jean-Francois Castilloux, MD, Flavia De-angelis, MD, Pierre Desjardins, MD, Michel Pavic, MD, Tamas Fulop, MD PhD

Blood (2018) 132 (Supplement 1): 4213.

https://doi.org/10.1182/blood-2018-99-117640

Published: 2018

Journal Articles

Clinical Characteristics of Elderly Chronic Myeloid Leukemia Patients in Korea; Based on the National Health Information Database

Jee Hyun Kong, MD, Tae-Hwa Go, Jung Yeon Lee, MD, Jieun Uhm, MD PhD, Shin Young Hyun, MD

Blood (2018) 132 (Supplement 1): 4262.

https://doi.org/10.1182/blood-2018-99-116158

Published: 2018

Journal Articles

Clinical Relevance of Clonal Hematopoiesis in the Oldest-Old Population: Analysis of the "Health and Anemia" Study

Blood (2018) 132 (Supplement 1): 750.

https://doi.org/10.1182/blood-2018-99-114717

Published: 2018

Journal Articles

Prothrombin Complex Concentrate Is Safe and Effective for Achieving Hemostasis in the Setting of Urgent Surgery for Patients Treated with Direct Xa Inhibitors

Merav Barzilai, MD, Ilya Kirgner, MD, Arza Steimatzky, MD, Dalit Salzer Gotler, MD, Yulia Belnick, MD, Irit Avivi, MD, David Varon, MD, Adi Shacham, MD, Vered Yahalom, MD, Sigal Nakav, PhD, Ethan Yussim, MD, Gil Bahar, MD, Uri Rozovski, Galia Spectre, MD PhD

Blood (2018) 132 (Supplement 1): 2541.

https://doi.org/10.1182/blood-2018-99-117378

Published: 2018

Journal Articles

Ibrutinib Monotherapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma: A Retrospective Single Center Experience from India

Rayaz Ahmed, MDDM, Dinesh Bhurani, MD DM, FRCPA, Narendra Agarwal, MD DM, Jyotsna Kapoor, MSc, Neha Gurha, MD, Manan Shah, MBBS, MHA, Prashant Narang, MD

Blood (2018) 132 (Supplement 1): 5561.

https://doi.org/10.1182/blood-2018-99-112348

Published: 2018

Journal Articles

Trends in the Utilization of Radiation Therapy (XRT) Among Patients with Non-Hodgkin's Lymphoma (NHL) in the United States (US)

Vivek Kumar, MD, M.B.,B.S., Taimur Sher, MD, Prakash Vishnu, MD, Vivek Roy, MD, Anne M Hazen, A.R.N.P.,M.S.N, Victoria R. Alegria, Meghna Ailawadhi, MD, Salman Ahmed, MD, Prachi Jani, MD, Zan Tahir Shareef, Sri Lekha Bodepudi, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2018) 132 (Supplement 1): 4765.

https://doi.org/10.1182/blood-2018-99-119981

Published: 2018

Journal Articles

Monoclonal Gammopathy of Undetermined Significance (MGUS): Indications for Pre-Diagnostic Testing, Subsequent Diagnoses, and Follow-up Practice

Aishwarya Ravindran, MBBS, Kandace A. Lackore, BS, Amy E. Glasgow, MHA, Matthew T. Drake, MD PhD, Ronald S. Go, MD

Blood (2018) 132 (Supplement 1): 2224.

https://doi.org/10.1182/blood-2018-99-118213

Published: 2018

Journal Articles

Incidence and Risk Factors for Central Nervous System Relapse in Very Elderly Patients over 80 with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of Two Lysa Studies

Aurelie Cabannes-Hamy, MD, Frederic Peyrade, MD, Fabrice Jardin, MD PhD, Jean-Francois Emile, Sylvie Castaigne, MD PhD, Bertrand Coiffier, MD PhD, Corinne Haioun, MD, Aurore Perrot, MD, Olivier Fitoussi, MD, Safia Chebrek, Christophe Fruchart, Julie Abraham, MD, Richard Delarue, MD, Marc Andre, MD, Gilles Salles, MD PhD, Philippe Gaulard, MD PhD, Herve Tilly, MD PhD, Catherine Thieblemont, MD PhD

Blood (2016) 128 (22): 927.

https://doi.org/10.1182/blood.V128.22.927.927

Published: 2016

Journal Articles

Uncompromised 10-year survival of oldest old carrying somatic mutations in DNMT3A and TET2

Blood (2016) 127 (11): 1512–1515.

https://doi.org/10.1182/blood-2015-12-685925

Published: 2016

Includes: Supplemental data

Journal Articles

Comparing the Outcome of Diffuse Large B-Cell Lymphoma in Very Elderly Patients (age greater than 80 years) with Elderly Patients (age between 65 to 79 years)

Charalampos S. Floudas, MD PhD MS, Ajay Dhakal, MBBS, Sunjay Neupane, Pouyan Gohari, MD, Abhinav B Chandra, MD MSc, FACP

Blood (2015) 126 (23): 5072.

https://doi.org/10.1182/blood.V126.23.5072.5072

Published: 2015

Journal Articles

Azatidine Treatment in Very Elderly Patients Diagnosed with Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

Javier Gutierrez, MD, Elena Morales, MD, Matilde Gonzalez, MD, Juan Herrada, MD

Blood (2015) 126 (23): 5262.

https://doi.org/10.1182/blood.V126.23.5262.5262

Published: 2015

Journal Articles

The First Registry: Follow-up in Rivaroxaban Patients in the Setting of Venous Thromboembolism

Kathryn Jane Lang, MRCP, MBBS, Vicente Solis, Jignesh Patel, PhD, Julia Czuprynska, MBBS, Lara N Roberts, MD, Raj Patel, Roopen Arya

Blood (2015) 126 (23): 4737.

https://doi.org/10.1182/blood.V126.23.4737.4737

Published: 2015

Journal Articles

Changes in Survival of Older Patients with Hematologic Malignancies in the Early 21 st Century

Dianne Pulte, MD, Lina Jansen, PhD, Felipe Castro, PhD, Hermann Brenner, MD MPH

Blood (2015) 126 (23): 3288.

https://doi.org/10.1182/blood.V126.23.3288.3288

Published: 2015

Journal Articles

First Line Chronic Lymphocytic Leukemia Immunochemotherapy for the Elderly Patients over 79 Years Is Feasible, and Achieves Good Results: A Filo Retrospective Study

Blood (2015) 126 (23): 4170.

https://doi.org/10.1182/blood.V126.23.4170.4170

Published: 2015

Journal Articles

Examination of the Prognosis and Health-Related Quality of Life of Elderly Patients with Malignant Lymphoma

Fumihito Tajima, MD PhD, Nozomi Hamada, RN, Tetsuo Yamamoto, MD PhD, Rika Hasegawa, RN, Masae Higashimori, RN, Toshio Kawatani, MD PhD

Blood (2015) 126 (23): 5601.

https://doi.org/10.1182/blood.V126.23.5601.5601

Published: 2015

Journal Articles

Time Trend and Age-Period-Cohort Effects on the Incidence of Patients with Adult T-Cell Leukemia in a Population-Based Study in Japan, 1991-2010

Masako Iwanaga, MD PhD MPH, Midori Soda, MD

Blood (2014) 124 (21): 2616.

https://doi.org/10.1182/blood.V124.21.2616.2616

Published: 2014

Journal Articles

Diffuse Large B Cell Lymphoma in Very Elderly Patients

Ajay Dhakal, MBBS, Pouyan Gohari, MD, Charalampos Floudas, MD, Sanjay Neupane, MBBS, Abhinav B Chandra, MD MSc

Blood (2014) 124 (21): 5453.

https://doi.org/10.1182/blood.V124.21.5453.5453

Published: 2014

Journal Articles

A Proposed Prognostic Model For Overall Survival In The Oldest Old (>80 Years Old) Follicular Lymphoma Patients

Chadi Nabhan, MD, FACP, Michelle Byrtek, PhD, Keith L Dawson, DNP, RN, Xiaolei Zhou, MS, Brian K Link, MD, Jonathan W. Friedberg, MD, Andrew D. Zelenetz, MD, PhD, James R Cerhan, MD, PhD, Christopher R. Flowers, MD, MS

Blood (2013) 122 (21): 3058.

https://doi.org/10.1182/blood.V122.21.3058.3058

Published: 2013

NARROW

Incidence and Survival of Multiple Myeloma; A Population-Based Study on 10 961 Patients Diagnosed 1982-2017

Factors Relating to the Favorable Outcome in Reduced-Dose R-CHOP Therapy for Elderly DLBCL Patients

Management of Diffuse Large B Cell Lymphoma in the Oldest Old—Insight into the Management Decision Process: A Canadian Perspective

Clinical Characteristics of Elderly Chronic Myeloid Leukemia Patients in Korea; Based on the National Health Information Database

Clinical Relevance of Clonal Hematopoiesis in the Oldest-Old Population: Analysis of the "Health and Anemia" Study

Prothrombin Complex Concentrate Is Safe and Effective for Achieving Hemostasis in the Setting of Urgent Surgery for Patients Treated with Direct Xa Inhibitors

Ibrutinib Monotherapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma: A Retrospective Single Center Experience from India

Trends in the Utilization of Radiation Therapy (XRT) Among Patients with Non-Hodgkin's Lymphoma (NHL) in the United States (US)

Monoclonal Gammopathy of Undetermined Significance (MGUS): Indications for Pre-Diagnostic Testing, Subsequent Diagnoses, and Follow-up Practice

Incidence and Risk Factors for Central Nervous System Relapse in Very Elderly Patients over 80 with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of Two Lysa Studies

Uncompromised 10-year survival of oldest old carrying somatic mutations in DNMT3A and TET2

Comparing the Outcome of Diffuse Large B-Cell Lymphoma in Very Elderly Patients (age greater than 80 years) with Elderly Patients (age between 65 to 79 years)

Azatidine Treatment in Very Elderly Patients Diagnosed with Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

The First Registry: Follow-up in Rivaroxaban Patients in the Setting of Venous Thromboembolism

Changes in Survival of Older Patients with Hematologic Malignancies in the Early 21 st Century

First Line Chronic Lymphocytic Leukemia Immunochemotherapy for the Elderly Patients over 79 Years Is Feasible, and Achieves Good Results: A Filo Retrospective Study

Examination of the Prognosis and Health-Related Quality of Life of Elderly Patients with Malignant Lymphoma

Time Trend and Age-Period-Cohort Effects on the Incidence of Patients with Adult T-Cell Leukemia in a Population-Based Study in Japan, 1991-2010

Diffuse Large B Cell Lymphoma in Very Elderly Patients

A Proposed Prognostic Model For Overall Survival In The Oldest Old (>80 Years Old) Follicular Lymphoma Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only